UBS Group »

Foghorn Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $151k 23k 6.45
2023-09-30 $52k 10k 5.00
2023-06-30 $87k 12k 7.04
2023-03-31 $48k 7.7k 6.20
2022-12-31 $32k 5.0k 6.38
2022-03-31 $45k 2.9k 15.40
2021-12-31 $158k 6.9k 22.92
2021-03-31 $28k 2.1k 13.11
2020-12-31 $46k 2.2k 20.46